On 2 March, FDA’s Device Good Manufacturing Practice Advisory Committee will meet for the first time since 2013 to discuss the agency’s proposal. The meeting materials, and the meeting itself, could offer the first glimpse at the future of the QSR.
I have it on my calendar, and I don’t currently work with medical devices. That has changed before and can change again. More importantly, this QSR update is an important milestone for those who watch the FDA’s take on quality systems and is worth attending.
Investigations of a Dog 